NASDAQ:CGC (Canopy Growth)
About CGC
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (NASDAQ: CGC) Latest News
Cannabis Stocks
Can Canopy Growth Stock Compete in the U.S.?
Coronavirus
3 Stocks I’d Buy Before Bitcoin
Investing
Young Investors: Should You Buy Bitcoin or Cannabis Stocks in March?
Energy Stocks
3 Top Canadian Stocks to Buy With $50 for Superior Returns
Investing
Why a Market Pullback Is the Best Time to Buy Stocks
Coronavirus
4 Top TSX Stocks to Make You Lucky
Cannabis Stocks
2 Marijuana Stocks That Could Be Millionaire Makers
Energy Stocks
4 High-Growth Canadian Stocks to Buy Under $50
Cannabis Stocks
3 Top Cannabis Stocks to Buy Right Now